Astera Labs Inc (NASDAQ:ALAB)’s traded shares stood at 3.82 million during the last session, with the company’s beta value hitting 0.33. At the close of trading, the stock’s price was $69.22, to imply an increase of 5.99% or $3.91 in intraday trading. The ALAB share’s 52-week high remains $147.39, putting it -112.93% down since that peak but still an impressive 47.67% since price per share fell to its 52-week low of $36.22. The company has a valuation of $11.42B, with an average of 2.7 million shares in intraday trading volume over the past 10 days and average of 4.64 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Astera Labs Inc (ALAB), translating to a mean rating of 1.40. Of 7 analyst(s) looking at the stock, 0 analyst(s) give ALAB a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 6 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.28.
Astera Labs Inc (NASDAQ:ALAB) trade information
After registering a 5.99% upside in the last session, Astera Labs Inc (ALAB) has traded red over the past five days. The 5-day price performance for the stock is 7.23%, and 11.63% over 30 days. With these gigs, the year-to-date price performance is -47.74%. Short interest in Astera Labs Inc (NASDAQ:ALAB) saw shorts transact 10.19 million shares and set a 2.66 days time to cover.
The extremes give us $100 and $110 for target low and target high price respectively. As such, ALAB has been trading -58.91% off suggested target high and -44.47% from its likely low.
Astera Labs Inc (ALAB) estimates and forecasts
The rating firms project that company’s revenue will grow 70.39% compared to the previous financial year.
Revenue forecast for the current quarter as set by 11 analysts is 151.55M. Meanwhile, for the current quarter, a total of 10 analyst(s) estimate revenue growth to 159.53M.Earnings reports from the last fiscal year show that sales brought in 65.26M and 76.85M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 132.23% before jumping 107.58% in the following quarter.
ALAB Dividends
Astera Labs Inc has its next earnings report out on 2025-Feb-09. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Astera Labs Inc (NASDAQ:ALAB)’s Major holders
Astera Labs Inc insiders hold 15.60% of total outstanding shares, with institutional holders owning 68.66% of the shares at 81.35% float percentage. In total, 68.66% institutions holds shares in the company, led by FMR LLC. As of 2024-06-30, the company held over 23.35 million shares (or 15.0454% of shares), all amounting to roughly $1.41 billion.
The next major institution holding the largest number of shares is INTEL CORP with 5.9 million shares, or about 3.8036% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $357.21 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund as the top two Mutual Funds with the largest holdings of the Astera Labs Inc (ALAB) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 3.73 shares. This is just over 2.26% of the total shares, with a market valuation of $258.36 million. Data from the same date shows that the other fund manager holds a little less at 3.4, or 2.06% of the shares, all valued at about 235.31 million.
